DOCSLIB.ORG

OTC Bulletin,30 July 2010, Page 1)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
OTC Bulletin,30 July 2010, Page 1) OTC16-12-10p1.qxd 14/12/10 06:35 Page 1 16 December 2010 COMPANY NEWS 3 Reckitt Benckiser set to buy Sinclair signs Decapinol 3 partner in US 36.6 resurrects its 4 India’s Paras for INR32.6bn expansion strategy Navamedic secures rights 5 to NYDA in three markets eckitt Benckiser is set to boost its con- GNC quiet on takeover 5 Rsumer healthcare business by acquiring speculation India’s Paras Pharmaceuticals for INR32.6 Mag-Ox buy fails to offset 6 billion (C546 million). OTC sales drop at Hi-Tech The premium price tag represents more than Beiersdorf to cut offering 7 eight-times Paras’ sales of INR4.0 billion in the as it focuses on skincare year to March 2010, and nearly 30-times the company’s operating earnings before interest, GENERAL NEWS 8 tax, depreciation and amortisation (EBITDA) of INR1.1 billion. McNeil recalls Rolaids 8 in Canada and the US The deal comes soon after Reckitt Benck- iser expanded its consumer healthcare business Buying Paras will give Reckitt Benckiser a portfolio of Three pharmacy bodies 9 OTC brands in India including Moov topical analgesics speak with single voice with the purchase of SSL International and its Durex and Scholl brands for £2.54 billion (C3.02 Paras’ personal-care business, meanwhile, ASA gives Lyclear 11 the all-clear in UK billion) (OTC bulletin,30 July 2010, page 1). was led by the Set Wet brand of hair gels and Commenting on the Paras deal, Bart Becht, deodorants for men, the company said. MARKETING NEWS 12 Reckitt Benckiser’s chief executive officer,said The deal will also give Reckitt Benckiser a the growth potential of the business, the cre- new state-of-the-art and Good Manufacturing Clarityn’s fast acting claim 12 ation of a material healthcare business in India’s Practice compliant manufacturing plant in Nor- is stopped in UK by MHRA large and growing healthcare market, and the thern India, which employs around 700 people. Happy and healthy kids 13 global synergies available made Paras an “ex- Becht said the Paras deal was another step star in PediaCare spots citing addition” to the company’s portfolio. forward in Reckitt Benckiser’s consumer health- Flucalyptol offers France 15 Reckitt Benckiser pointed out that acquir- care growth strategy. “We believe the Paras ‘free access’ pholcodine ing privately-held Paras would give it a port- business has extremely good growth potential Anadin gets a boost in UK 17 folio of Indian OTC brands with leading mar- when supported by Reckitt Benckiser’s invest- with effervescent ibuprofen ket positions, including India’s number two ment and innovation strength,”he added. Coughing animals promote 18 topical analgesic pain ointment Moov and the Reckitt Benckiser’s Health & Personal Care Buttercup’s benefits in UK number two cold and flu remedy D’Cold. division is the company’s largest, with sales of FEATURES 20 Paras also marketed Krack, India’s leading £1.67 billion in the first nine months of 2010 medicated skin treatment for cracked heels, (OTC bulletin,16 November 2010, page 4). 2010 turns out to 20 Reckitt Benckiser pointed out, along with the It represented 27% of Reckitt Benckiser’s total be an eventful year Itch Guard and Ring Guard antifungal creams. sales for the period of £6.18 billion. Recalls, acquisitions, people on the move, traditional herbal medicines and food claims were hot topics in 2010 Kindler makes abrupt GSK adds muscle REGULARS departure from Pfizer with Maxinutrition Consumer viewpoint 10 – Erectile dysfunction is effrey Kindler has stepped down as chair- laxoSmithKline Consumer Healthcare is the topic of this month’s Jman and chief executive officer of Pfizer, Gpoised to expand its Nutritional Health- European consumer survey and retired from the company with immedi- care business by acquiring Maxinutrition from Events – Our regular listing 19 ate effect. Darwin Private Equity for approximately £162 People – NBTY names Nagel 22 In the wake of Kindler’s abrupt departure, million (C192 million) including the repay- as its new chief executive the US-based pharmaceutical firm has nam- ment of outstanding debt. People – Merck raises Frazier 23 ed Ian Read, 57, head of its global biopharm- Described as “Europe’s number one sports to chief executive officer ■ Continued on page 8 ■ Continued on page 7 Gen 4-COL Ad FOR OTC Promo Flash -Oct 2010.qxd 19/10/10 07:09 Page 1 News@Gen TO FREE Keep ahead of your competition. Subscribe to SUBSCRIBERS: ericsbulleti n YOU’RE MISSING OUT! Until now,you’ve had to gather information to find what subscr take out ibers can you need to know.Generics bulletin changes that. asubscriptionnow Generics bulletin provides asingle source of accurate, regularand to reliable commercial and regulatory information for the global generics industry. It is essential reading for managing asuccessful business in for just£ (£400 376 the increasingly fast-moving world of generic medicines. outside Eur Save Reporting what’shappening from agenerics ‘angle’, Generics bulletin nearly ope) provides strategic insights by means of in-depth features and exclusive price 25% ss on interviews. It also examines the impact of actions taken by research-based hown below! pharma firms, and decisions reached by governments, law courts, patent offices, and regulatory agencies. All Generics bulletin From the same publisher as the well-respected OTC bulletin –first published in 1993 – Generics bulletin provides the inside story on product launches, company subscribers receive a FREE mergers and acquisitions, and patent, pricing and reimbursement issues. weekly electronic newsflash – Add to that a FREE weekly electronic news service, and Generics bulletin News@Genericsbulletin – represents avital information resource you cannot afford to be without. which keeps them fully updated with the biggest stories breaking in the worldwide generic pharmaceuticals sector. SUBSCRIPTION FORM PLEASE TICK APPROPRIATE BOXES DELIVERYADDRESS ❏ Iwould like ___________ annual subscription/s to Generics bulletin at the rate of Name____________________________________________ Position________________________ £495 (£525outside Europe) for single copies and £275 (£305 outside Europe) for additional copies to the same address Company ________________________________________________________________________ ❏ Please send me asample copy of Generics bulletin Address__________________________________________________________________________ PAYMENT OPTIONS _________________________________________________________________________________ ❏ Ienclose acheque for £_____, or the euro/dollar equivalent _____, drawn on aUKbank Cheques should be made payable to Generics bulletin _________________________________________________________________________________ ❏ Please debit my credit cardfor £______ Tel___________________________________ Fax ________________________________________ ❏ VISA ❏ MASTERCARD ❏ AMERICAN EXPRESS E-mail address for News@Genericsbulletin________________________________________ CardNo: Please returnformto: Three/four-digit security code: Generics bulletin,Bulletin Publishing Group, OTC Publications Ltd, 54 Creynolds Lane, Solihull B90 4ER, UK. Or Fax to: +44 (0)1564 777524 Cardholder signature______________________________________________________________ Telephone enquiries: +44 (0)1564 777550 E-mail: [email protected] Expirydate:____________________________Date _____________________________________ Registered Office: As above. Registered in England No 2765878. VATNoGB608 0432 69 For more information visit our website at www.Generics-bulletin.com OTC16-12-10p2-3FIN.qxd 14/12/10 06:37 Page 3 COMPANY NEWS OTC Distribution Agreements Sinclair signs Decapinol partner in US inclair Pharma has signed up Sunstar Amer- in the Asia-Pacific region, and had acquired Sicas to relaunch its Decapinol mouthwash the rights to the Kelo-cote wound care brand in the US. Sunstar will market Decapinol as an in the UK and Germany. OTC product under its GUM brand name. Sunstar – which already markets Sinclair’s Under the terms of the agreement, said Sin- Aloclair mouth-ulcer gel and mouth rinse in the clair,Sunstar had also taken an option to lic- Americas region under the GUM Canker-X and ense Decapinol in Japan once the product had GUM Rincinol brand names – would return De- been registered, as well as further options cov- capinol to the US market during 2011,Sinclair ering several other countries where the prod- pointed out, and would market the product uct was not currently marketed. through pharmacies and other US retailers to The deal was struck shortly after Sinclair appeal to the “health-conscious consumer”. announced that it had teamed up with biophar- Previously,Decapinol had been available maceutical firm Invida to launch its dermatol- in the US under the Impede brand name. How- ogy and wound care products across 11 markets ever,in November of last year Sinclair said it had mutually agreed to terminate its US distri- bution deal with the Johnson & Johnson sub- OTC bulletin sidiary Orapharma, so that the product could be repositioned for the OTC market (OTC bul- Sinclair’s Decapinol mouthwash will be sold by 16 December 2010 Number 354 letin,30 November 2009, page 2). Sunstar under its GUM brand name in the US Sinclair claimed its “ecological” approach Editor & Publisher: Deborah Wilkes to oral hygiene was in marked contrast to the Invida would market the brands to general Associate Editors: Aidan Fry standard antiseptic mouthwashes that current- practitioners, dermatologists and paediatricians, Mike Rice ly dominated the US$750 million (C566
Load more

Recommended publications
  • Category of Supplement Types of Claims Examples of Claims (2007) Enforceme Nt? •Germs Are Everywhere
    Referred to Gov Date of Decision Type Challenger Advertiser Product Agency for Category of Supplement Types of Claims Examples of Claims (2007) Enforceme nt? •Germs are everywhere. Take Airborne to boost your immune system, fight viruses and help you stay Case •Performance 4648 3/26/2007 NAD Airborne Health Inc. Airborne Immune Health healthy. Report •Implied •Take Airborne. The immune boosting tablet that helps your body fight germs. •Clinically Proven/Shown •CH-Alpha is scientifically proven to promote joint health. 4652 Case Report 4/10/2007 NAD Gelita Health Products CH-Alpha Joint Health •Preventative Health •After just two to three months, you will regain the freedom of flexibility. •94% faster recovery [from colds] •Clinically Proven/Shown •Increased immune system resistance by 312% 4653 Case Report 4/10/2007 Proctor and Gamble Iovate Health Sciences Inc. Cold MD Immune Health •Speed •Clinically Proven results •Comparative •Doctor formulated and approved •Chromax helps your insulin function at its best. •Performance •It's an advanced, highly absorbable form of chromium that provides your body with the chromium it Blood Sugar Health •Insulin 4547 Compliance 4/11/2007 NAD Nutrition 21 Chromax needs to help promote healthy blood sugar, fight carbohydrate cravings and support your overall •Implied cardiovascular health. •Essential for optimum insulin health. •Exclusivity •One-A-Day Women's Multi-Vitamin is the only complete multi-vitamin with more calcium for strong 4672 Case Report 5/1/2007 NAD Bayer Consumer Healthcare One-A-Day Women's Multi-Vitamin •Implied bones, and now more vitamin D, which emerging research suggests may support breast cancer.
    [Show full text]
  • Novartis Set to Introduce Pantoloc in 14 Countries
    OTC10-02-10p1FIN.qxd 8/2/10 07:43 Page 1 10 February 2010 COMPANY NEWS 2 Novartis set to introduce Switzerland’s Mepha aims 2 at herbals and supplements Alliance Boots to establish 3 Swedish pharmacy venture Pantoloc in 14 countries Ta isho suffers as OTC market cools 4 J&J hit by comparison and currency 6 ovartis Consumer Health is set to in- the product is available without a prescription Ntroduce Nycomed’s proton-pump in- in Australia. NBTY’s pre-tax profits soar 7 hibitor Pantoloc Control as a non-prescrip- Novartis said that it would introduce Panto- Demand for OTC specialties 8 tion medicine in 14 European countries. loc Control in the 14 countries “later in 2010” lifts annual sales at Boiron The 20mg pantoprazole tablets gained non- through a co-marketing agreement with Nyco- Prilosec OTC hit by Prevacid 9 prescription status across Europe in June of last med. “The launch will be backed by substan- MiraLAX rival drives Perrigo 10 year through the European Union’s centralis- tial investment to build consumer awareness Omega offsets tough 11 ed authorisation procedure (OTC bulletin,19 and demand,”the company commented, “as start to grow sales June 2009, page 1). well as pharmacy training to help pharmacy Cadbury’s shareholders agree 12 Nycomed has since introduced the medi- teams identify customers who will benefit most to Kraft takeover cine for frequent heartburn in Austria, Estonia, from Pantoloc Control and advise those cus- William Ransom agrees to 13 Finland, France, Germany, Hungary,Latvia, tomers appropriately.” divest Manuka Gold Lithuania, the Netherlands,Norway,Poland, Brian McNamara, head of Europe for Nov- GENERAL NEWS 14 Sweden and Switzerland.
    [Show full text]
  • Office Results
    Raymond Wayne Whitted MD, MPH, FACOG …dedicated to safe, state-of-the-art surgery and health life-styles for women of all ages …because quality is an experience! www.drwhitted.net The Skinny on Weight Loss Supplements: Fact or Fantasy? Introduction Nowadays, it seems as though most Americans are trying to lose weight, and for good reason: about 97 million Americans are overweight or obese.[1] These patients have increased risk of all-cause mortality, as well as increased morbidity from hypertension, dyslipidemia, type 2 diabetes, coronary heart disease, stroke, gallbladder disease, osteoarthritis, sleep apnea, and other respiratory problems, as well as certain malignancies, such as cancers of the endometrium, prostate, and breast.[1] The National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Disease published guidelines for the treatment of overweight and obese adults.[1] These recommendations are intended for patients with a body mass index (BMI) ≥ 30, or ≥ 27 with obesity-related risk factors or diseases present. The guidelines recommend initial lifestyle modifications, including a reduced-calorie diet of 500-1000 calories per day, increased physical activity, and behavioral therapy. If these changes fail to produce a result in 6 months, approved pharmacotherapy is recommended as an adjunct in high-risk patients. Prescription medications approved by the US Food and Drug Administration (FDA) for weight loss include: sibutramine (Meridia, by Abbott Laboratories), which inhibits the reuptake of serotonin, norepinephrine, and dopamine; orlistat (Xenical, by Roche Laboratories Inc.), a reversible inhibitor of gastric and pancreatic lipase; and phentermine, an adrenergic medication.[2] Less commonly prescribed drugs include diethylpropion, benzphetamine, and phendimetrazine.
    [Show full text]
  • Handbook of PREBIOTICS and PROBIOTICS INGREDIENTS Health Benefits and Food Applications
    Handbook of PREBIOTICS AND PROBIOTICS INGREDIENTS Health Benefits and Food Applications Handbook of PREBIOTICS AND PROBIOTICS INGREDIENTS Health Benefits and Food Applications Edited by SUSAN SUNGSOO CHO E. TERRY FINOCCHIARO Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2010 by Taylor and Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number: 978-1-4200-6213-7 (Hardback) This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmit- ted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers.
    [Show full text]
  • Brasil-Ingredientes-Trends-2020.Pdf
    Ingredients Campinas ­ SP 1ª Edição Ficha catalográfica elaborada pela Área de Documentação e Informação do Centro deTecnologia de Embalagem – CETEA Brasil ingredients trends 2020 [recurso eletrônico] / editores, Airton Vialta, Raul Amaral Rego – 1. ed. – Campinas : ITAL, 2014. 389 p. : il. ; 27 cm. ISBN 978-85-7029-124-0 1. Ingredientes alimentícios. 2. Alimentos processados. 3. Suplementos alimentares. I. Vialta, Airton. II. Garcia, Aline de Oliveira. III. Lemos, Ana Lúcia da Silva Correa. IV. Van Dender, Ariene Gimenes Fernandes. V. Bucione, Ary. VI. Gallina, Darlila Aparecida. VII. Marasca, Elza Teresinha Grael. VIII. Lajolo, Franco. IX. Alvim, Izabela Dutra. X. Moreno, Izildinha. XI. Madi, Luis. XII. Soler, Márcia. XIII. Berto, Maria Isabel. XIV. Silva, Marta Gomes da. XV. Zacarchenco, Patrícia Blumer. XVI. Rego, Raul Amaral. XVII. Instituto de Tecnologia de Alimentos. XVIII. Título. PRO IA - I M B X R E A - S T IL IA FI AN GOVERNO DO ESTADO DE SÃO PAULO Governador: Geraldo Alckmin SECRETARIA DE AGRICULTURA E ABASTECIMENTO ­ SAA Secretária: Mônika Bergamaschi Secretário­Adjunto: Alberto José Macedo Filho Chefe de Gabinete: Silvio Manginelli AGÊNCIA PAULISTA DE TECNOLOGIA DOS AGRONEGÓCIOS ­ APTA Coordenador: Orlando Melo de Castro INSTITUTO DE TECNOLOGIA DE ALIMENTOS – ITAL Diretor­Geral: Luis Madi Instituto de Tecnologia de Alimentos – ITAL Av. Brasil, 2.880 CEP: 13070­178 – Campinas­SP www.ital.sp.gov.br Criado em 30 de agosto de 1963, pelo Governo do Estado de A dinâmica do setor de ingredientes demonstra claramente que São Paulo, com o objetivo de auxiliar o desenvolvimento o segmento de alimentação e nutrição caminha de forma científico e tecnológico do setor industrial de alimentos, acelerada na direção de estágios avançados de tecnologia bebidas e embalagens, o ITAL adaptou-se, nesses 50 anos, embarcada.
    [Show full text]
  • Healing*Edge Sciences
    Extended Catalog Healing*Edge Science 102 Super Horny Goat Weed - 60 caps $12.50 4 EVER FIT 5219 Turbo Energy - 60 tabs $8.50 ID Description Price 2758 Yohimbe Power Max 2000 - 100 caps $20.50 6382 4Ever Whey Isolate Gainer Chocolate Shake - 8 $51.25 lbs 5646 Yohimbe Power Max 2000 - 2 fl.oz $14.25 6352 4Ever Whey Isolate Gainer Vanilla Shake - 8 lbs $51.25 AIRBORNE 6354 4Ever Whey Protein Chocolate Shake - 4 lbs $32.50 8825 4Ever Whey Protein Vanilla Shake - 4 lbs $32.50 ID Description Price 8308 Creatine Monohydrate - 500 gr $11.95 9017 Airborne Lemon-Lime - 30 tabs $17.50 7457 F4rmula Lean Muscle Meal Chocolate - 2 lbs $25.98 8171 Airborne Lemon-Lime - 36 tabs $17.50 7455 F4rmula Lean Muscle Meal Cookies & Cream - 2 $25.98 8529 Airborne Pink Grapefruit - 30 tabs $17.50 lbs 8659 Airborne Zesty Orange - 30 tabs $17.50 7456 F4rmula Lean Muscle Meal Vanilla - 2 lbs $25.98 9127 Airborne Zesty Orange - 30 tabs $17.50 6383 Fruit Blast the Isolate Tropical Mango - 5 lbs $59.95 7204 Fruit Blast the Natural Tropical Splash - 2 lbs $30.49 AJINOMOTO 6452 Fruit Blast the Whey Cranrazz - 5 lbs $32.50 ID Description Price 8826 Fruit Blast the Whey Mango Magic - 4 lbs $32.50 8311 Amino Vital 7500 Recovery and Energy ER Arctic $37.05 Lemon - 16 oz 9393 Fruit Blast the Whey Strawberry Kiwi - 4 lbs $32.50 9466 Amino Vital 7500 Recovery and Energy ER Fuji $37.05 6394 Fruit Blast the Whey Tangy Orange - 5 lbs $29.95 Apple - 16 oz 6471 L-Glutamine - 1000 gr $33.95 7196 Amino Vital Conditioning - 90 caps $18.90 6395 L-Glutamine - 500 gr $20.98 7352 Amino
    [Show full text]
  • Research.Pdf (960.2Kb)
    PROBIOTIC-SUPPLEMENTED SOY BAR EFFECTS ON RESISTANCE TO INFECTION BY LISTERIA MONOCYTOGENES ________________________________________________________________ A thesis presented to the Faculty of the Graduate School University of Missouri ________________________________________________________________ In Partial Fulfillment Of the Requirements for the Degree Master of Science ________________________________________________________________ by MARIELIS TORRES-MEDINA Dr. Azlin Mustapha, Thesis Supervisor DECEMBER 2008 The undersigned, appointed by the dean of the Graduate School, have examined the thesis entitled PROBIOTIC-SUPPLEMENTED SOY BAR EFFECTS ON RESISTANCE TO INFECTION BY LISTERIA MONOCYTOGENES presented by Marielis Torres-Medina, a candidate for the degree of Master of Science, and hereby certify that, in their opinion, it is worthy of acceptance. Dr. Azlin Mustapha, Food Science Dr. Kevin L. Fritsche, Animal Science Dr. Mark Ellersieck, Food Science ACKNOWLEDGEMENTS Many people have contributed to the success of this work, and have been with me along the way of this whole experience. I would like to express my sincere appreciation to Dr. Azlin Mustapha for giving me the opportunity to work on this project and letting me become part of the food microbiology lab. Also, for her assistance and advice along this journey. Special thanks to Dr. Kevin Fritsche for not just being on my committee but for always encouraging me and helping me during this process. My gratitude to Dr. Mark Ellersieck for being part of my committee and helping me with the statistical analysis of this project. I want to mention my immense gratitude to my lab mates Luxin, Mo, Atreyee, Rosemary, Yajun and Warren. Guys, thank you for saving my life with the in-vivo study; I could never have done it without you.
    [Show full text]
  • NBJ's Supplement Business Report
    NBJ’s Supplement Business 2011 Report An analysis of markets, trends, competition and strategy in the U.S. dietary supplement industry NBJ’s Supplement Business Report 2011 2 www.nutritionbusinessjournal.com ©2011 Penton Media, Inc. Table of Contents 2.1. ACKNOWLEDGEMENTS ................................................................................................................................................... 23 2.2. RESEARCH METHODOLOGY ............................................................................................................................................. 23 2.2.1. Disclaimer ........................................................................................................................................................ 24 2.2.2. Copyright ......................................................................................................................................................... 24 2.3. DEFINITIONS ................................................................................................................................................................. 24 2.3.1. Product Categories .......................................................................................................................................... 24 2.3.2. Sales Channels ................................................................................................................................................. 26 3.1. U.S. NUTRITION INDUSTRY ............................................................................................................................................
    [Show full text]